Doherty David T 4

What Happened
David T. Doherty, Chief Financial Officer of Surgery Partners (SGRY), reported a sale of 8,867 shares on March 16, 2026. The shares were disposed at a weighted average price of $12.50 per share, for total proceeds of $110,838. The filing notes the sale was made to satisfy tax‑withholding obligations related to restricted stock that vested on March 4, 2026.

Key Details

• Transaction date: 2026-03-16 (reported on the same date).
• Transaction type: Sale (reported as "open market or private sale"); proceeds = $110,838.
• Price: $12.50 (weighted average); filing states full per‑price breakdown is available upon request.
• Reason: Sold to satisfy tax withholding on vested restricted stock (footnote).
• Shares owned after transaction: Not specified in this filing.
• Filing timeliness: Reported with the 2026-03-16 report date (no late‑filing indication).

Context
This sale was executed to cover tax withholding for vested restricted stock (a common, routine reason for insider sales) rather than an outright market-timing purchase/sell decision. Footnote disclosure (F2) indicates the reported price is a weighted average and more detailed price-by-price information can be provided to the SEC or shareholders on request.